Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Neoplasms 5Parasomnias 4Depression 3Weight Loss 2Tuberous Sclerosis 2Smith-Magenis Syndrome 2Sleep Wake Disorders 2Polycystic Ovary Syndrome 2Pain 2Lung Neoplasms 2Fatigue 2Cachexia 2Autism Spectrum Disorder 2Anxiety Disorders 2Angelman Syndrome 2Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Sleep Disorders, Circadian Rhythm 1Relapsed Malignant Solid Tumor 1Radiodermatitis 1Radiation Injuries 1Quality of Life 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Melanoma 1Leukoplakia, Oral 1Keratosis, Actinic 1Hematologic Neoplasms 1Head and Neck Neoplasms 1

Interventions

Propofol 1Melatonin 1Electroencephalography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sleep Disorders, Circadian Rhythm × Melatonin × Clear all
NCT03205033 2017-07-02

Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

Hospital de Clinicas de Porto Alegre

Phase 2 Completed
36 enrolled
Breast

Breast Neoplasms, Depression, Pain, Sleep Disorders, Circadian Rhythm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡